ArticleClinical ophthalmology (Auckland, N.Z.)2013

Safety and efficacy of MIM-D3 ophthalmic solutions in a randomized, placebo-controlled Phase 2 clinical trial in patients with dry eye.

Karen Meerovitch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.